Trilaciclib Prevents Myelosuppression With Chemoradiotherapy
Clinical trial NCT06490081 · UNKNOWN
Trial details
- NCT number
- NCT06490081
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-26
- Primary completion
- 2026-01-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.